RNS Number : 6767G Renalytix PLC 28 July 2021     Renalytix Appoints Ann Berman to its Board of Directors   Berman serves on the board of Lowes Corporation , is a member of the board of trustees of Beth Israel Deaconess , and is a former chief financial officer of Harvard University     NEW YORK

NEW YORK, July 26, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (LSE: RENX) (NASDAQ: RNLX) (“Renalytix” or the “Company”) today announced the company will be presenting at the upcoming 41 st Annual Canaccord Genuity Virtual Global Growth Conference. Renalytix’s management is scheduled to present at the

RNS Number : 3061G Renalytix PLC 23 July 2021   Renalytix plc   (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 23 July 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O. James Sterling , the Company's Chief Financial Officer, of 12,000

Hutson to Build on Renalytix Quality and Regulatory Strategy for KidneyIntelX Global Commercialization NEW YORK and SALT LAKE CITY, July 22, 2021 (GLOBE NEWSWIRE) -- Renalytix Plc (NASDAQ: RNLX) (LSE: RENX) today announced the appointment of Joseph Hutson as its Vice President of Quality and

RNS Number : 0685G Renalytix PLC 22 July 2021   Renalytix plc   (" Renalytix " or the " Company ")     Renalytix Appoints Joseph Hutson Vice President of Global Quality and Regulatory   Hutson To Build-on Renalytix Quality and Regulatory Strategy for KidneyIntelX Global Commercialization   NEW YORK

RNS Number : 7167F Renalytix PLC 19 July 2021   Renalytix plc   (" Renalytix " or the " Company ")     Exercise of Options and TVR   NEW YORK , 19 July, 2021 - Renalytix plc (AIM: RENX) announces that it has issued and allotted 5,000 ordinary shares of 0.25 pence each in the share capital of the

RNS Number : 3722E Renalytix PLC 07 July 2021   Renalytix plc   (" Renalytix " or the " Company ")     Exercise of options, PDMR transaction and TVR   NEW YORK , 7 July, 2021 - The Board of   Renalytix plc (LSE: RENX) announces that it has issued and allotted 27,500 ordinary shares of 0.25 pence

RNS Number : 9118D Renalytix PLC 01 July 2021   Renalytix plc   (" Renalytix " or the " Company ")     Death of Director     NEW YORK , 1 July, 2021 - The Board of   Renalytix plc (LSE: RENX) (NASDAQ: RNLX) is saddened to announce the death of Dr. Barbara Murphy , Non-Executive Director and

RNS Number : 7147D Renalytix PLC 01 July 2021   Renalytix plc   (" Renalytix " or the " Company ")     Total voting rights   The Company's total issued share capital consists of 72,197,286 shares of 0.25 pence each, with each share carrying the right to one vote.

Study Results lay foundation for KidneyIntelX repeat testing, reimbursement, and pharma collaborations NEW YORK, June 28, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (LSE: RENX) (NASDAQ: RNLX) announces new data demonstrating KidneyIntelX™ can be effective at monitoring therapeutic response and